| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | — |
| R&D Expense | $1.0M | -84.4% |
| SG&A Expense | $3.7M | -21.2% |
| Operating Income | -$3.1M | +72.7% |
| Income Tax | $2K | — |
| Net Income | -$2.9M | +75.0% |
| EPS (Basic) | -$0.93 | +94.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | +10.1% |
| Total Assets | $2.9M | +9.7% |
| Current Liabilities | $1.1M | +34.7% |
| Total Liabilities | $1.1M | +34.7% |
| Stockholders' Equity | $1.8M | -34.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +79.7% |
| Financing Cash Flow | $2.1M | -78.7% |